![Chih Hung Yeh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chih Hung Yeh
Directeur Général chez
TAIWAN LIPOSOME COMPANY, LTD.
Profil
Currently, Chih Hung Yeh is General Manager & Director at Taiwan Liposome Co., Ltd. since 2002; Director at TLC Biopharmaceuticals HK Ltd., TLC Biopharmaceuticals Pty Ltd., Woods Investment Co. Ltd.; Managing Director at TLC Biopharmaceuticals B.V.; General Manager & Director at TLC Biopharmaceuticals Shanghai Ltd.; President & Director at TLC Biopharmaceuticals Japan Co., Ltd.; Director at Steminent Biotherapeutics, Inc. since 2021; and General Manager at TLC Biopharmaceuticals, Inc. Formerly, Mr. Yeh was Associate at General Bank; Chief Financial Officer at Hermes Biosciences, Inc. from 2002 to 2005; and Vice President at Asiawired Group from 1999 to 2002.
Education includes undergraduate studies at the University of California, Berkeley, and graduate studies including an MBA at the University of Michigan.
Postes actifs de Chih Hung Yeh
| Sociétés | Poste | Début |
|---|---|---|
| TAIWAN LIPOSOME COMPANY, LTD. | Directeur Général | - |
| STEMINENT BIOTHERAPEUTICS INC. | Directeur/Membre du Conseil | 08/12/2021 |
TLC Biopharmaceuticals, Inc.
 TLC Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel nanomedicines | Corporate Officer/Principal | - |
TLC Biopharmaceuticals HK Ltd. | Directeur/Membre du Conseil | - |
TLC Biopharmaceuticals B.V. | Directeur Général | - |
TLC Biopharmaceuticals Shanghai Ltd. | Directeur Général | - |
TLC Biopharmaceuticals Pty Ltd. | Directeur/Membre du Conseil | - |
TLC Biopharmaceuticals Japan Co., Ltd. | President | - |
Woods Investment Co. Ltd.
 Woods Investment Co. Ltd. Financial ConglomeratesFinance Provides investment services | Directeur/Membre du Conseil | - |
Anciens postes connus de Chih Hung Yeh
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Chih Hung Yeh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
General Bank
 General Bank Major BanksFinance Provides commercial banking services | Finance |
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Hermes Biosciences, Inc.
 Hermes Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops extracellular vesicle isolation system that process bodily fluid and cell culture media to purify exosomes | Commercial Services |
Asiawired Group | |
TLC Biopharmaceuticals, Inc.
TLC Biopharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel nanomedicines | Health Technology |
TLC Biopharmaceuticals HK Ltd. | |
TLC Biopharmaceuticals B.V. | |
TLC Biopharmaceuticals Shanghai Ltd. | |
TLC Biopharmaceuticals Pty Ltd. | |
TLC Biopharmaceuticals Japan Co., Ltd. | |
Steminent Biotherapeutics, Inc.
 Steminent Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of stem cell drugs and technology for neurodegenerative disorders | Health Technology |
Woods Investment Co. Ltd.
Woods Investment Co. Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
